SNY:NASDAQ
Sanofi
40,07 US$
arrow_downward
-0,40%(-0,16) 1 d
40,25 US$
arrow_upward
+0,46% (+0,18)bedtimeFuera de horario
Cerrado: 9 oct, 16:00:00 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de SNY...
Abrir
40,17 US$
Alto
40,30 US$
Bajo
39,92 US$
Cap. burs.
95,52 mil M
Vol. medio
2,77 M
Volumen
2,10 M
Dividendo
6,04 %
Dividendo trimestral
0,60 US$
Fecha exdividendo
5 may 2026
Ratio PER
21,93
Máximo en 52 sem.
52,68 US$
Mínimo en 52 sem.
39,18 US$
BPA
1,83 US$
Beta
0,37
Acciones en circulación
2415,55 M
N.º de empleados
75 mil
Abrir
40,17 US$
Alto
40,30 US$
Bajo
39,92 US$
Cap. burs.
95,52 mil M
Vol. medio
2,77 M
Volumen
2,10 M
Dividendo
6,04 %
Dividendo trimestral
0,60 US$
Fecha exdividendo
5 may 2026
Ratio PER
21,93
Máximo en 52 sem.
52,68 US$
Mínimo en 52 sem.
39,18 US$
BPA
1,83 US$
Beta
0,37
Acciones en circulación
2415,55 M
N.º de empleados
75 mil
Noticias
De fuentes web y partners de noticias
AD HOC NEWS
·
hace 13 horas
Sanofi stock is unchanged at 0.00 percent as weekly high reaches EUR 71.92
AD HOC NEWS
·
hace 1 día
Sanofi stock after-hours at EUR 71.82: plus 0.06 percent
AD HOC NEWS
·
hace 1 día
Jefferies keeps Buy rating for Sanofi stock at EUR 100 target
AD HOC NEWS
·
hace 3 días
Sanofi stock gains 1.02 percent as antibody deal advances pipeline
Perfil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Acerca de Sanofi
CEOBelén Garijo | Paul Hudson
Empleados74,8 mil
Fundación1973
SedeParís, Isla de Francia, Francia
Sector-
Sitio websanofi.com